Back

Answers in CME Inc. (AiCME)

  • Bronchiectasis
  • Fibrosis

Relieving the Weight of Non-Cystic Fibrosis Bronchiectasis: Updated Strategies for an Evolving Landscape

An educational accredited activity will focus on improving clinicians knowledge and competence in the management of NCFB. As a result of this educational activity, learners should be better able to: 1. Recognize the rationale for targeting neutrophilic inflammation in non-cystic fibrosis bronchiectasis (NCFB); 2. Describe the clinical impact of DPP1 inhibitors for treating NCFB, in the context of conventional therapy; and, 3. Apply strategies to enhance outcomes for patients with NCFB as the treatment landscape evolves. Learners have access to downloadable materials.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 0.5 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • Microlearning
  • Credit · Up to 0.5 credits
  • Commercial Support
  • Released
    Oct 31, 2025
  • Last day to claim credit
    Oct 31, 2026 3 weeks left